loadpatents
name:-0.022502183914185
name:-0.015240907669067
name:-0.007667064666748
OGURO; Yuya Patent Filings

OGURO; Yuya

Patent Applications and Registrations

Patent applications and USPTO patent grants for OGURO; Yuya.The latest application filed is for "heterocyclic compound and use thereof".

Company Profile
6.14.19
  • OGURO; Yuya - Kanagawa JP
  • OGURO; Yuya - Fujisawa-shi JP
  • Oguro; Yuya - Fujisawa JP
  • Oguro; Yuya - Tsukuba N/A JP
  • Oguro; Yuya - Kanawaga JP
  • OGURO; Yuya - Tsukuba-shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterocyclic Compound And Use Thereof
App 20220089525 - OGURO; Yuya ;   et al.
2022-03-24
Heterocyclic compound
Grant 11,230,541 - Kimura , et al. January 25, 2
2022-01-25
Heterocyclic Compound And Use Thereof
App 20210332053 - OGURO; Yuya ;   et al.
2021-10-28
Heterocyclic compound and use thereof
Grant 10,807,987 - Oguro , et al. October 20, 2
2020-10-20
Heterocyclic Compound
App 20200231579 - KIMURA; Eiji ;   et al.
2020-07-23
Heterocyclic compound
Grant 10,610,520 - Ikeda , et al.
2020-04-07
Heterocyclic Compound And Use Thereof
App 20190300536 - OGURO; Yuya ;   et al.
2019-10-03
Heterocyclic compound
Grant 10,323,026 - Ikeda , et al.
2019-06-18
Heterocyclic Compound
App 20190125728 - IKEDA; Shuhei ;   et al.
2019-05-02
Heterocyclic compound
Grant 10,131,653 - Kamei , et al. November 20, 2
2018-11-20
Heterocyclic Compound
App 20180155333 - KAMEI; Taku ;   et al.
2018-06-07
Heterocyclic Compound
App 20170283406 - Ikeda; Shuhei ;   et al.
2017-10-05
Heterocyclic Compound
App 20170209452 - HOMMA; Misaki ;   et al.
2017-07-27
Heterocyclic compound
Grant 9,655,900 - Homma , et al. May 23, 2
2017-05-23
Heterocyclic Compound
App 20160310494 - HOMMA; Misaki ;   et al.
2016-10-27
Heterocyclic compound
Grant 9,388,195 - Homma , et al. July 12, 2
2016-07-12
Heterocyclic Compound
App 20150158882 - HOMMA; Misaki ;   et al.
2015-06-11
Heterocyclic compound
Grant 8,933,069 - Homma , et al. January 13, 2
2015-01-13
Heterocyclic Compound
App 20140228352 - HOMMA; Misaki ;   et al.
2014-08-14
Thienopyrimidine as CDC7 kinase inhibitors
Grant 8,691,828 - Oguro , et al. April 8, 2
2014-04-08
Fused heterocyclic derivative and use thereof
Grant 8,399,449 - Fujii , et al. March 19, 2
2013-03-19
Heterocyclic Compound
App 20130029969 - Homma; Misaki ;   et al.
2013-01-31
Fused heterocycle derivatives and use thereof
Grant 8,304,557 - Oguro , et al. November 6, 2
2012-11-06
Fused heterocyclic derivative and use thereof
Grant 8,217,176 - Oguro July 10, 2
2012-07-10
Thienopyrimidine As Cdc7 Kinase Inhibitors
App 20120040981 - Oguro; Yuya ;   et al.
2012-02-16
Heterocyclic Compound
App 20110034469 - HASHIMOTO; Kentaro ;   et al.
2011-02-10
Fused Heterocyclic Derivative And Use Thereof
App 20110003788 - Fujii; Nobuhiro ;   et al.
2011-01-06
Fused Heterocyclic Derivative And Use Thereof
App 20090227561 - FUJII; Nobuhiro ;   et al.
2009-09-10
Fused Heterocycle Derivatives And Use Thereof
App 20090163488 - OGURO; Yuya ;   et al.
2009-06-25
Fused Heterocyclic Derivatives and Use Thereof
App 20090137580 - Imamura; Shinichi ;   et al.
2009-05-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed